Medicare Moves to Improve Equity in Drug, Managed Care Plans

Beneficiaries in private Medicare Advantage plans and Medicare Part D prescription drug plans can expect improved transparency and lower out-of-pocket costs for medications under a final rule issued Friday by the Biden administration.

The final rule (RIN 0938-AU30) provides a number of enhancements designed to improve access and advance health equity for people who qualify for both Medicare and Medicaid.

“The Biden-Harris Administration has remained committed to ensuring equity in health care for all,” Chiquita Brooks-LaSure, administrator of the Centers for Medicare & Medicaid Services, said in a statement. “This rule improves the health care experience and affordability for millions ...